enVVeno Medical Corp Quarterly Nonoperating Income (Expense) in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
enVVeno Medical Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q3 2024.
  • enVVeno Medical Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $528K, a 51.7% increase year-over-year.
  • enVVeno Medical Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.17M, a 57.8% increase year-over-year.
  • enVVeno Medical Corp annual Nonoperating Income (Expense) for 2023 was $1.72M, a 555% increase from 2022.
  • enVVeno Medical Corp annual Nonoperating Income (Expense) for 2022 was $263K, a 27.9% decline from 2021.
  • enVVeno Medical Corp annual Nonoperating Income (Expense) for 2021 was $365K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.17M $528K +$180K +51.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.99M $498K +$158K +46.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $1.83M $511K +$106K +26.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.72M $629K +$349K +125% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.37M $348K +$294K +544% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.08M $340K +$416K Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $663K $405K +$400K +8000% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $263K $280K +$276K +6900% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$13K $54K -$264K -83% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $251K -$76K -$84K -1050% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-31
Q1 2022 $335K $5K -$30K -85.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $365K $4K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $318K +$370K Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $8K +$89K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $35K +$384K Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q3 2020 -$491K -$52.5K -$33.3K -174% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$457K -$81K -$67.1K -482% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$390K -$349K -$340K -3948% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$49.9K -$8.23K +$9.05K +52.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$59K -$19.1K +$342 +1.76% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$59.3K -$13.9K -$1.95M -101% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.89M -$8.62K -$3.3M -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q4 2018 $5.19M -$17.3K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$19.5K -$462K -104% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $1.93M +$1.92M +11162% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $3.29M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 $443K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $17.2K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.